News & Blog

Latest from the Blog

  1. January 7, 2021

    New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

    Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

    Read more | 
  2. December 19, 2020

    4 Big Takeaways From the 2020 Annual Meeting of the Society for Neuro-Oncology

    A move to a virtual platform didn’t diminish the quality of the 2020 Annual Meeting of the Society for Neuro-Oncology (SNO), the yearly gathering of the world’s foremost brain tumor researchers and clinicians. As usual, the National Brain Tumor Society was a proud platinum sponsor of this important conference and deployed our own team of […]

    Read more | 
  3. November 10, 2020

    National Brain Tumor Society Congratulates President-elect Joe Biden

    National Brain Tumor Society (NBTS) offers our congratulations to President-elect Joe Biden and Vice President-elect Kamala Harris. President-elect Biden, more so than any other president in U.S. history, personally understands the devastating nature of brain tumors following the loss of his son, Beau, to glioblastoma. He and his wife, Dr. Jill Biden, care deeply about […]

    Read more | 
Share